Abstract
Objective
To assess the relationship between meal consumption frequency and assisted reproductive technology (ART) outcomes among female patients with infertility.Research methods & procedures
This cohort study was conducted from February 2022 to January 2024 at Tokyo Medical University Hospital. Overall, 101 female patients with infertility issues and without a history of stroke, heart disease, cancer, or type 1 or type 2 diabetes were enrolled in this study. The factors extracted from the questionnaire included demographic information, meal consumption frequency before ART and at 20 years of age, smoking status, and alcohol consumption status. Data on other factors, including age, body mass index, anti-Müllerian hormone level, and parity history, were collected from medical records. The assessed clinical outcomes included number of transplanted embryos, clinical pregnancies, ongoing pregnancies, live births, and miscarriages.Results
After adjusting for potential confounding factors, including age, smoking status, alcohol consumption status, body mass index, anti-Müllerian hormone level, and parity history, a multivariate analysis of ART outcomes was performed. Patients were categorized into groups based on the frequency of weekly consumption of breakfast, lunch, and dinner. Patients who consumed breakfast 6-7 times a week were significantly more likely to have higher rates of live birth and lower rates of miscarriage in pregnancies conceived through ART.Conclusions
Consumption of breakfast 6-7 times a week before ART was associated with increased success rates following ART. This highlights the potential importance of regular breakfast consumption for optimizing ART outcomes.Citations & impact
This article has not been cited yet.
Impact metrics
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/166798856
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
No specific adverse pregnancy outcome in singleton pregnancies after assisted reproductive technology (ART) for unexplained infertility.
J Gynecol Obstet Hum Reprod, 49(1):101623, 22 Aug 2019
Cited by: 0 articles | PMID: 31446168
Assisted reproductive technology use and outcomes among women with a history of cancer.
Hum Reprod, 31(1):183-189, 17 Nov 2015
Cited by: 27 articles | PMID: 26577302 | PMCID: PMC4677965
Assisted reproductive technology surveillance--United States, 2000.
MMWR Surveill Summ, 52(9):1-16, 01 Aug 2003
Cited by: 34 articles | PMID: 14532867
Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer).
Cochrane Database Syst Rev, 2:CD011809, 28 Feb 2018
Cited by: 9 articles | PMID: 29489026 | PMCID: PMC6491093
Review Free full text in Europe PMC
Funding
Funders who supported this work.
Japan Society for the Promotion of Science (5)
Grant ID: JP20H03996
Grant ID: JP21K18297
Grant ID: JP22K09556
Grant ID: JP21H04837
Grant ID: JP22K18396